Skip to Main Content

Paper Details

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential.
Blood Adv
3
2022
BC, CHIP, Clonal hematopoiesis of indeterminate potential, Patient, breast cancer, cancer, heart disease, hematological malignancy, participants, patient, patients, women
Author NameAffiliation
Christopher J GibsonDana-Farber Cancer Institute
Christopher J GibsonHarvard Medical School, Harvard University
Kathryn J RuddyMayo Clinic
Jeffrey PeppercornHarvard Medical School, Harvard University
Jeffrey PeppercornMassachusetts General Hospital
Donna NeubergDana-Farber Cancer Institute
Benjamin L EbertDana-Farber Cancer Institute
Benjamin L EbertHarvard Medical School, Harvard University
Benjamin L EbertHoward Hughes Medical Institute
  • 1 - 9

Datasets

Release 1.2